FindTrial
Sign In

Effect of maternal fish oil supplementation on infants' physical and mental development: a perspective randomized control trial

Effect of maternal fish oil supplementation on infants' physical and mental development: a perspective randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001302
Enrollment
Unknown
Registered
2011-04-26
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children development

Interventions

General dose:Fish oil containing a total amount of 2.8 grams long chain n-3 fatty acids
Low dose:A 1:3 mixture of fish oil to olive oil, containing a total amount of 0.7 grams long chain n-3 fatty acids
Control:Olive oil, containing no long chain n-3 fatty acids

Sponsors

SIPPR
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Women pregnant in weeks 16-24 of gestation those are planned to deliver at the collaborating hospital.

Exclusion criteria

Exclusion criteria: 1. abetes mellitus in or before pregnancy; 2. Diagnosed severe fetal malformation or hydrops in current pregnancy; 3. Suspicion in current pregnancy, or occurrence in an earlier pregnancy, of placental abruption; 4. Drug or alcohol abuse; 5. Regular intake of fish oil or of nonsteroidal anti-inflammatory agents or other drugs with an effect on thrombocyte function or eicosanoid metabolism; 6. Allergy to fish products.

Design outcomes

Primary

MeasureTime frame
Infant sychomotor Development Index (PDI);Infant Mental Development Index (MDI);—

Countries

China

Contacts

Public ContactYan Che
che_yan2004@yahoo.com.cn+86 021 64046391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026